ArticleBrain : a journal of neurology2020

NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients.

Sunny Malhotra et al.PubMed ↗Publisher ↗

No numbers read from the abstract.